American Society of Clinical Oncology policy statement: oversight of clinical research.
about
Institutional shared resources and translational cancer researchClinical research nursing: a critical resource in the national research enterpriseConsenting of the vulnerable: the informed consent procedure in advanced cancer patients in Mexico.Participation in clinical research: perspectives of adult patients and parents of pediatric patients undergoing hematopoietic stem cell transplantationQuality evaluation of investigator-initiated trials using post-approval cancer drugs in Japan.Physician and stakeholder perceptions of conflict of interest policies in oncology.Oncologists' recommendations of clinical trial participation to patientsConduct, Oversight, and Ethical Considerations of Clinical Trials in Companion Animals with Cancer: Report of a Workshop on Best Practice Recommendations.Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common ruleOffering results to research subjects: U.S. Institutional Review Board policy.Oncologists and medical malpractice.Institutional review boards and bioethical issues for otologists and audiologistsParental views on tissue banking in pediatric oncology patients.Demographic analysis of randomized controlled trials in bladder cancer.Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment.Tools to optimize the functionality of a leukemia clinical trial team.Protecting boundaries of consent in clinical research: implications for improvement.Ethical issues in health research in children
P2860
Q24288943-39C30312-AE5F-4395-ABB0-E5B924E8246FQ26998407-FB52E562-C366-49FC-BFE9-C22DB5A21C61Q30478688-AA564A6C-5643-4014-832E-029329F20964Q30586919-0B1177B5-A49C-46EE-AB90-6161D237486CQ33738869-1FB9A781-690D-41CA-BD97-78A5CDF91D07Q35916899-821FCD01-AAF4-4603-8D73-7858D0067A2FQ36470363-A46E5727-F0C4-4BE0-8BDB-3E03F6B182C5Q37020305-865BFB04-8317-4C98-A30C-38012865E11AQ37024565-57C7B13F-9156-408A-BD51-49848BAC1B66Q37076098-E9BFA570-CD39-4A7B-A0F1-A1197D19DBA7Q37476179-303759B5-3C86-48C2-B1CC-4D274089096EQ37606561-63F29A4B-9B4B-4014-9F21-2669D4AF0BC9Q37831280-637C2080-8D5A-4312-BD5F-BAE3495D1EEEQ38038683-EB27E75F-3CDB-44D4-88FB-5C6164202ABEQ41439334-672A9703-7287-4519-97FE-6A62CA846F41Q42657232-B60DD32F-B6CB-464A-9F80-1580E10CB5CFQ43507616-44F23251-B261-4D7A-BE8F-9CA3C4E66976Q56783697-92D0FB65-7F7F-4B78-823A-F7E789A4E42B
P2860
American Society of Clinical Oncology policy statement: oversight of clinical research.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
American Society of Clinical Oncology policy statement: oversight of clinical research.
@ast
American Society of Clinical Oncology policy statement: oversight of clinical research.
@en
type
label
American Society of Clinical Oncology policy statement: oversight of clinical research.
@ast
American Society of Clinical Oncology policy statement: oversight of clinical research.
@en
prefLabel
American Society of Clinical Oncology policy statement: oversight of clinical research.
@ast
American Society of Clinical Oncology policy statement: oversight of clinical research.
@en
P356
P1476
American Society of Clinical Oncology policy statement: oversight of clinical research.
@en
P304
P356
10.1200/JCO.2003.04.026
P407
P577
2003-04-29T00:00:00Z